Title: Nickel compounds are novel inhibitors of histone H4 acetylation.
Authors: Broday, L; Peng, W; Kuo, M H; Salnikow, K; Zoroddu, M; Costa, M
Published In Cancer Res, (2000 Jan 15)
Abstract: Environmental factors influence carcinogenesis by interfering with a variety of cellular targets. Carcinogenic nickel compounds, although generally inactive in most gene mutation assays, induce chromosomal damage in heterochromatic regions and cause silencing of reporter genes when they are located near telomere or heterochromatin in either yeast or mammalian cells. We studied the effects of nickel on the lysine acetylation status of the NH2-terminal region of histone H4. At nontoxic levels, nickel decreased the levels of histone H4 acetylation in vivo in both yeast and mammalian cells, affecting only lysine 12 in mammalian cells and all of the four lysine residues in yeast. In yeast, lysine 12 and 16 were more greatly affected than lysine 5 and 8. Interestingly, a histidine Ni2+ anchoring site is found at position 18 from the NH2-terminal tail of H4. Nickel was also found to inhibit the acetylation of H4 in vitro using purified recombinant histone acetyltransferase. To our knowledge, this is the first agent shown to decrease histone H4 acetylation at nontoxic levels.
PubMed ID: 10667566
MeSH Terms: Acetylation; Acetyltransferases/antagonists & inhibitors*; Cadmium Chloride/pharmacology; Copper Sulfate/pharmacology; Histidine; Histone Acetyltransferases; Histones/chemistry; Histones/isolation & purification; Histones/metabolism*; Humans; Lung Neoplasms; Nickel/pharmacology*; Saccharomyces cerevisiae Proteins*; Saccharomyces cerevisiae/metabolism; Tumor Cells, Cultured